semaglutide dapagliflozin Type 2 diabetes mellitus pharmacological remission with plus oral GLP-1 & SGLT2 Inhibitor Combination
Description
Timing is also a useful clue
Other GLP1 R agonists have been studied in PD and are reviewed elsewhere [35]
An additive effect on weight loss was also observed in AWARD-10, which studied the GLP-1-RA dulaglutide versus placebo in patients already on SGLT2 inhibitors with 0.9 kg additional weight loss, 98 although SUSTAIN-9 found that semaglutide superimposed on SGLT2 inhibition resulted in 3.8 kg of additional weight loss and a reduction of HbA1c of 1.42
This guide covers everything: the clinical evidence behind the combination, exactly how each medication works at the cellular level, practical protocols for taking both, strategies for managing overlapping side effects , and the specific situations where your prescriber might adjust one or both medications
Article GLP-1 Receptor agonists in non-alcoholic fatty liver disease: Current evidence and future perspectives
How can GLP-1 receptor agonists benefit people with type 2 diabetes and chronic kidney disease (CKD)
